MetaCap

Lineage Cell Therapeutics (LCTX) News

NYSE: LCTXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

0.7719-0.0481 (-5.87%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

LCTX news summary

We found 4 recent headlines mentioning Lineage Cell Therapeutics (LCTX): 0 in the past week and 4 in the past 30 days, most often from Business Wire, Nasdaq. LCTX is making an outsized move today, down 5.87% at $0.7719, which often coincides with company-specific news. Check the latest headlines below for the likely catalyst. The most recent story, "Lineage (LCTX) Q3 2026 Earnings Call Transcript", was published by Nasdaq on Nov 13, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest Lineage Cell Therapeutics headlines

Stocks mentioned alongside LCTX

Compare LCTX